» Articles » PMID: 17686468

Evidence for Differential Changes of Junctional Complex Proteins in Murine Neurocysticercosis Dependent Upon CNS Vasculature

Overview
Journal Brain Res
Specialty Neurology
Date 2007 Aug 10
PMID 17686468
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The delicate balance required to maintain homeostasis of the central nervous system (CNS) is controlled by the blood-brain barrier (BBB). Upon injury, the BBB is disrupted compromising the CNS. BBB disruption has been represented as a uniform event. However, our group has shown in a murine model of neurocysticercosis (NCC) that BBB disruption varies depending upon the anatomical site/vascular bed analyzed. In this study further understanding of the mechanisms of BBB disruption was explored in blood vessels located in leptomeninges (pial vessels) and brain parenchyma (parenchymal vessels) by examining the expression of junctional complex proteins in murine brain infected with Mesocestoides corti. Both pial and parenchymal vessels from mock infected animals showed significant colocalization of junctional proteins and displayed an organized architecture. Upon infection, the patterned organization was disrupted and in some cases, particular tight junction and adherens junction proteins were undetectable or appeared to be undergoing proteolysis. The extent and timing of these changes differed between both types of vessels (pial vessel disruption within days versus weeks for parenchymal vessels). To approach potential mechanisms, the expression and activity of matrix metalloproteinase-9 (MMP-9) were evaluated by in situ zymography. The results indicated an increase in MMP-9 activity at sites of BBB disruption exhibiting leukocyte infiltration. Moreover, the timing of MMP activity in pial and parenchymal vessels correlated with the timing of permeability disruption. Thus, breakdown of the BBB is a mutable process despite the similar structure of the junctional complex between pial and parenchymal vessels and involvement of MMP activity.

Citing Articles

Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.

Church M, Ceja G, McGeehan M, Miller M, Farias P, Sanchez M J Immunol. 2021; 207(1):44-54.

PMID: 34162727 PMC: 8695639. DOI: 10.4049/jimmunol.2000514.


Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.

Cangalaya C, Zimic M, Marzal M, Gonzalez A, Guerra-Giraldez C, Mahanty S PLoS Negl Trop Dis. 2015; 9(12):e0004207.

PMID: 26658257 PMC: 4689503. DOI: 10.1371/journal.pntd.0004207.


Epigenetic Modulation of Microglial Inflammatory Gene Loci in Helminth-Induced Immune Suppression: Implications for Immune Regulation in Neurocysticercosis.

Chauhan A, Quenum F, Abbas A, Bradley D, Nechaev S, Singh B ASN Neuro. 2015; 7(4).

PMID: 26148848 PMC: 4552224. DOI: 10.1177/1759091415592126.


Helminth induced suppression of macrophage activation is correlated with inhibition of calcium channel activity.

Chauhan A, Sun Y, Pani B, Quenumzangbe F, Sharma J, Singh B PLoS One. 2014; 9(7):e101023.

PMID: 25013939 PMC: 4094426. DOI: 10.1371/journal.pone.0101023.


Pericytes: brain-immune interface modulators.

Hurtado-Alvarado G, Cabanas-Morales A, Gomez-Gonzalez B Front Integr Neurosci. 2014; 7:80.

PMID: 24454281 PMC: 3887314. DOI: 10.3389/fnint.2013.00080.


References
1.
Prat A, Biernacki K, Wosik K, Antel J . Glial cell influence on the human blood-brain barrier. Glia. 2001; 36(2):145-55. DOI: 10.1002/glia.1104. View

2.
Gloor S, Wachtel M, Bolliger M, Ishihara H, Landmann R, Frei K . Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev. 2001; 36(2-3):258-64. DOI: 10.1016/s0165-0173(01)00102-3. View

3.
Huber J, Egleton R, Davis T . Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001; 24(12):719-25. DOI: 10.1016/s0166-2236(00)02004-x. View

4.
Shaw S, Perkins B, Lim Y, Liu Y, Nusrat A, Schnell F . Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte.... Am J Pathol. 2001; 159(6):2281-91. PMC: 1850595. DOI: 10.1016/s0002-9440(10)63078-7. View

5.
Tsukita S, Furuse M, Itoh M . Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol. 1999; 11(5):628-33. DOI: 10.1016/s0955-0674(99)00016-2. View